Insider · CIK 0001766117
Maarten Wensveen
officer
Files at CMPR (CIMPRESS plc). First filing Nov 5, 2025, latest Nov 5, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $1.6M sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
CMPR: CIMPRESS plc
CMPROct 9, 2026 · close 74.21
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 60Notable | CMPRsell CIMPRESS plc | $1.6M 22,830 shares | -53% | +74% from low-18% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Nov 15, 2025 | CMPR CIMPRESS plc | MOption exercise Ordinary Shares | +1,860 | $0.00 | $0 | 22,447 | Nov 18, 2025 |
| Nov 15, 2025 | CMPR CIMPRESS plc | MOption exercise Ordinary Shares | +3,697 | $0.00 | $0 | 26,144 | Nov 18, 2025 |
| Nov 15, 2025 | CMPR CIMPRESS plc | MOption exercise Ordinary Shares | +1,303 | $0.00 | $0 | 27,447 | Nov 18, 2025 |
| Nov 15, 2025 | CMPR CIMPRESS plc | FTax withholding Ordinary Shares | -3,319 | $66.59 | $221k | 24,128 | Nov 18, 2025 |
| Nov 15, 2025 | CMPR CIMPRESS plc | MOption exercise Restricted Share Units (right to acquire)derivative | -1,860 | $0.00 | $0 | 5,580 | Nov 18, 2025 |
| Nov 15, 2025 | CMPR CIMPRESS plc | MOption exercise Performance Share Unitsderivative | -3,697 | $0.00 | $0 | 25,878 | Nov 18, 2025 |
| Nov 15, 2025 | CMPR CIMPRESS plc | MOption exercise Performance Share Unitsderivative | -1,303 | $0.00 | $0 | 14,333 | Nov 18, 2025 |
| Nov 3, 2025 | CMPR CIMPRESS plc | SOpen-market sale Ordinary Shares | -21,010 | $68.24 | $1.4M | 22,407 | Nov 5, 2025 |
| Nov 3, 2025 | CMPR CIMPRESS plc | SOpen-market sale Ordinary Shares | -1,294 | $69.30 | $90k | 21,113 | Nov 5, 2025 |
| Nov 3, 2025 | CMPR CIMPRESS plc | SOpen-market sale Ordinary Shares | -526 | $70.74 | $37k | 20,587 | Nov 5, 2025 |
| Aug 15, 2025 | CMPR CIMPRESS plc | MOption exercise Ordinary Shares | +2,337 | $0.00 | $0 | 38,343 | Aug 15, 2025 |
| Aug 15, 2025 | CMPR CIMPRESS plc | MOption exercise Ordinary Shares | +1,860 | $0.00 | $0 | 40,203 | Aug 15, 2025 |
| Aug 15, 2025 | CMPR CIMPRESS plc | MOption exercise Ordinary Shares | +3,697 | $0.00 | $0 | 43,900 | Aug 15, 2025 |
| Aug 15, 2025 | CMPR CIMPRESS plc | MOption exercise Ordinary Shares | +5,212 | $0.00 | $0 | 49,112 | Aug 15, 2025 |
| Aug 15, 2025 | CMPR CIMPRESS plc | FTax withholding Ordinary Shares | -5,695 | $60.16 | $343k | 43,417 | Aug 15, 2025 |
| Aug 15, 2025 | CMPR CIMPRESS plc | MOption exercise Restricted Share Units (right to acquire)derivative | -2,337 | $0.00 | $0 | 0 | Aug 15, 2025 |
| Aug 15, 2025 | CMPR CIMPRESS plc | MOption exercise Restricted Share Units (right to acquire)derivative | -1,860 | $0.00 | $0 | 7,440 | Aug 15, 2025 |
| Aug 15, 2025 | CMPR CIMPRESS plc | MOption exercise Performance Share Unitsderivative | -3,697 | $0.00 | $0 | 29,575 | Aug 15, 2025 |
| Aug 15, 2025 | CMPR CIMPRESS plc | MOption exercise Performance Share Unitsderivative | -5,212 | $0.00 | $0 | 15,636 | Aug 15, 2025 |
| Aug 7, 2025 | CMPR CIMPRESS plc | AGrant or award Performance Share Unitsderivative | +20,848 | $0.00 | $0 | 20,848 | Aug 11, 2025 |
| May 15, 2025 | CMPR CIMPRESS plc | MOption exercise Ordinary Shares | +1,860 | $0.00 | $0 | 33,941 | May 19, 2025 |
| May 15, 2025 | CMPR CIMPRESS plc | MOption exercise Ordinary Shares | +3,697 | $0.00 | $0 | 37,638 | May 19, 2025 |
| May 15, 2025 | CMPR CIMPRESS plc | FTax withholding Ordinary Shares | -1,632 | $45.06 | $74k | 36,006 | May 19, 2025 |
| May 15, 2025 | CMPR CIMPRESS plc | MOption exercise Restricted Share Units (right to acquire)derivative | -1,860 | $0.00 | $0 | 9,300 | May 19, 2025 |
| May 15, 2025 | CMPR CIMPRESS plc | MOption exercise Performance Share Unitsderivative | -3,697 | $0.00 | $0 | 33,272 | May 19, 2025 |
| Feb 15, 2025 | CMPR CIMPRESS plc | MOption exercise Ordinary Shares | +3,563 | $0.00 | $0 | 29,262 | Feb 19, 2025 |
| Feb 15, 2025 | CMPR CIMPRESS plc | MOption exercise Ordinary Shares | +1,860 | $0.00 | $0 | 31,122 | Feb 19, 2025 |
| Feb 15, 2025 | CMPR CIMPRESS plc | MOption exercise Ordinary Shares | +3,697 | $0.00 | $0 | 34,819 | Feb 19, 2025 |
| Feb 15, 2025 | CMPR CIMPRESS plc | FTax withholding Ordinary Shares | -2,738 | $53.85 | $147k | 32,081 | Feb 19, 2025 |
| Feb 15, 2025 | CMPR CIMPRESS plc | MOption exercise Restricted Share Units (right to acquire)derivative | -3,563 | $0.00 | $0 | 0 | Feb 19, 2025 |
| Feb 15, 2025 | CMPR CIMPRESS plc | MOption exercise Restricted Share Units (right to acquire)derivative | -1,860 | $0.00 | $0 | 11,160 | Feb 19, 2025 |
| Feb 15, 2025 | CMPR CIMPRESS plc | MOption exercise Performance Share Unitsderivative | -3,697 | $0.00 | $0 | 36,969 | Feb 19, 2025 |
| Nov 15, 2024 | CMPR CIMPRESS plc | MOption exercise Ordinary Shares | +1,860 | $0.00 | $0 | 24,690 | Nov 19, 2024 |
| Nov 15, 2024 | CMPR CIMPRESS plc | MOption exercise Ordinary Shares | +3,697 | $0.00 | $0 | 28,387 | Nov 19, 2024 |
| Nov 15, 2024 | CMPR CIMPRESS plc | FTax withholding Ordinary Shares | -2,688 | $80.48 | $216k | 25,699 | Nov 19, 2024 |
| Nov 15, 2024 | CMPR CIMPRESS plc | MOption exercise Restricted Share Units (right to acquire)derivative | -1,860 | $0.00 | $0 | 13,020 | Nov 19, 2024 |
| Nov 15, 2024 | CMPR CIMPRESS plc | MOption exercise Performance Share Unitsderivative | -3,697 | $0.00 | $0 | 40,666 | Nov 19, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.